Epigral Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

41.55

41.55

41.55

41.55

41.55

Share application money

-

-

-

-

-

Preference share capital

55.00

110.00

-

-

-

Reserves & surplus

1,212.54

1,027.62

684.42

431.66

331.00

Loan funds

Secured loans

907.69

766.14

989.36

626.42

648.93

Unsecured loans

-

-

-

-

-

Total

2,216.78

1,945.31

1,715.33

1,099.64

1,021.48

Uses of funds

Fixed assets

Gross block

2,384.68

2,310.66

1,468.73

1,421.11

688.10

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

618.04

506.61

400.90

318.80

247.92

Net block

1,766.64

1,804.05

1,067.83

1,102.31

440.17

Capital work-in-progress

482.84

158.10

589.25

125.84

691.16

Investments

20.57

20.62

0.05

0.05

-

Net current assets

Current assets, loans & advances

524.28

449.48

466.53

220.55

142.13

Less : current liabilities & provisions

577.55

486.94

408.33

349.12

251.99

Total net current assets

-53.27

-37.46

58.20

-128.56

-109.85

Miscellaneous expenses not written

-

-

-

-

-

Total

2,216.78

1,945.31

1,715.33

1,099.64

1,021.48

Notes:

Book value of unquoted investments

20.57

20.57

-

0.05

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

222.10

293.41

242.60

393.53

82.77

Number of equity sharesoutstanding (Lacs)

415.50

415.50

415.50

415.53

415.53